Pharma Reaserch Prod Co Ltd - Asset Resilience Ratio

Latest as of December 2025: 42.03%

Pharma Reaserch Prod Co Ltd (214450) has an Asset Resilience Ratio of 42.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩438.71 Billion

≈ $297.31 Million USD Cash + Short-term Investments

Total Assets

₩1.04 Trillion

≈ $707.43 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Pharma Reaserch Prod Co Ltd's Asset Resilience Ratio has changed over time. Check 214450 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Pharma Reaserch Prod Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 214450 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩438.71 Billion	42.03%
Total Liquid Assets	₩438.71 Billion	42.03%

Asset Resilience Insights

Very High Liquidity: Pharma Reaserch Prod Co Ltd maintains exceptional liquid asset reserves at 42.03% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Pharma Reaserch Prod Co Ltd Industry Peers by Asset Resilience Ratio

Compare Pharma Reaserch Prod Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Pharma Reaserch Prod Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	42.03%	₩438.71 Billion ≈ $297.31 Million	₩1.04 Trillion ≈ $707.43 Million	+10.24pp
2024-12-31	31.79%	₩272.00 Billion ≈ $184.33 Million	₩855.70 Billion ≈ $579.90 Million	+14.40pp
2023-12-31	17.38%	₩93.05 Billion ≈ $63.06 Million	₩535.28 Billion ≈ $362.75 Million	-21.18pp
2022-12-31	38.56%	₩184.34 Billion ≈ $124.92 Million	₩478.06 Billion ≈ $323.97 Million	+1.89pp
2021-12-31	36.66%	₩156.79 Billion ≈ $106.26 Million	₩427.65 Billion ≈ $289.81 Million	+11.88pp
2020-12-31	24.78%	₩79.26 Billion ≈ $53.72 Million	₩319.83 Billion ≈ $216.75 Million	+16.36pp
2019-12-31	8.42%	₩22.74 Billion ≈ $15.41 Million	₩269.93 Billion ≈ $182.92 Million	-8.70pp
2018-12-31	17.12%	₩44.20 Billion ≈ $29.95 Million	₩258.19 Billion ≈ $174.97 Million	-27.64pp
2017-12-31	44.75%	₩84.60 Billion ≈ $57.33 Million	₩189.03 Billion ≈ $128.11 Million	-1.79pp
2016-12-31	46.55%	₩83.48 Billion ≈ $56.57 Million	₩179.33 Billion ≈ $121.53 Million	-1.85pp
2015-12-31	48.40%	₩81.95 Billion ≈ $55.54 Million	₩169.31 Billion ≈ $114.74 Million	--

pp = percentage points

About Pharma Reaserch Prod Co Ltd

KQ:214450 Korea Biotechnology

Market Cap

$2.38 Billion

₩3.52 Trillion KRW

Market Cap Rank

#5515 Global

#118 in Korea

Share Price

₩338500.00

Change (1 day)

-2.73%

52-Week Range

₩259000.00 - ₩711000.00

All Time High

₩711000.00